CN113559183A - A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method - Google Patents
A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method Download PDFInfo
- Publication number
- CN113559183A CN113559183A CN202111003503.0A CN202111003503A CN113559183A CN 113559183 A CN113559183 A CN 113559183A CN 202111003503 A CN202111003503 A CN 202111003503A CN 113559183 A CN113559183 A CN 113559183A
- Authority
- CN
- China
- Prior art keywords
- parts
- acanthopanax
- cerebrovascular diseases
- traditional chinese
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cerebrovascular diseases and a preparation method thereof, and relates to the technical field of medicines for treating cerebrovascular diseases, wherein the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 20-30 parts of acanthopanax rubrus, 20-30 parts of acanthopanax giraldii harms, 20-30 parts of acanthopanax rupestris, 10-15 parts of rhynchophylla, 5-10 parts of cinnamomum camphora, 5-10 parts of mint, 20-30 parts of acanthopanax arborescens, 10-15 parts of pumpkin seed powder and 5-10 parts of towel gourd fruit. The traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention adopts natural traditional Chinese medicines as raw material components, is green and safe, does not contain hormone, has no side effect, is low in price, can be taken for a long time, is convenient to take, has a remarkable effect on treating diseases caused by cerebrovascular blockage such as cerebral infarction, cerebral thrombosis, cerebral hemorrhage and the like, and has a cure rate of over 98%.
Description
Technical Field
The invention relates to the technical field of medicaments for treating cerebrovascular diseases, in particular to a traditional Chinese medicine composition for treating cerebrovascular diseases and a preparation method thereof.
Background
Cerebrovascular diseases are the general term for diseases causing cerebral dysfunction due to cerebrovascular diseases, mainly including local or diffuse cerebral dysfunction caused by various cerebrovascular diseases such as vascular lumen occlusion or stenosis, vascular rupture, vascular malformation, vascular wall injury or permeability change, but not including diffuse cerebral dysfunction caused by global cerebral ischemia or hypoxia caused by factors such as hemodynamic abnormality.
Cerebral infarction, cerebral thrombosis, cerebral hemorrhage are the most common cerebrovascular diseases. Most of the existing medicines for treating cerebrovascular diseases such as cerebral infarction, cerebral hemorrhage and the like are western medicines, are expensive, contain hormones, have obvious side effects, can damage organs such as intestines, stomach, liver and kidney and the like, can only relieve the illness state, cannot cure the illness state, and are not suitable for long-term administration.
At present, no traditional Chinese medicine composition which adopts natural traditional Chinese medicines as raw material components, is green and safe, has no side effect and low price and can be taken for a long time for treating cerebrovascular diseases exists.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a traditional Chinese medicine composition for treating cerebrovascular diseases and a preparation method thereof.
The traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 20-30 parts of acanthopanax rubrus, 20-30 parts of acanthopanax giraldii harms, 20-30 parts of acanthopanax rupestris, 10-15 parts of rhynchophylla, 5-10 parts of cinnamomum camphora, 5-10 parts of mint, 20-30 parts of acanthopanax arborescens, 10-15 parts of pumpkin seed powder and 5-10 parts of towel gourd fruit.
Preferably, the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 25 parts of acanthopanax rubrus, 25 parts of acanthopanax giraldii harms, 25 parts of acanthopanax senticosus, 12.5 parts of rhynchophylla, 7.5 parts of cinnamomum camphora, 7.5 parts of mint, 25 parts of acanthopanax giraldii harms, 12.5 parts of pumpkin seed powder and 7.5 parts of luffa down.
Preferably, the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 20 parts of acanthopanax rubrus, 20 parts of acanthopanax giraldii harms, 20 parts of acanthopanax gracilistylus, 10 parts of rhynchophylla, 5 parts of cinnamomum camphora, 5 parts of mint, 20 parts of acanthopanax giraldii harms, 10 parts of pumpkin seed powder and 5 parts of luffa down.
Preferably, the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 30 parts of acanthopanax rubrus, 30 parts of acanthopanax giraldii harms, 30 parts of acanthopanax gracilistylus, 15 parts of rhynchophylla, 10 parts of cinnamomum camphora, 10 parts of mint, 30 parts of acanthopanax giraldii harms, 15 parts of pumpkin seed powder and 10 parts of towel gourd velvet.
The preparation method of the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following steps:
s1, mixing the acanthopanax giraldii harms, the acanthopanax yantheri and the acanthopanax giraldii harms, wrapping and winding the mixture by using gauze to prepare a medicine bag A;
s2, wrapping the pumpkin seed powder with gauze to obtain a medicine bag B;
s3, mixing the medicine bag A, the medicine bag B, the rhynchophylla, the camphor, the mint and the towel gourd velvet, adding water into the mixture, and decocting to obtain the traditional Chinese medicine composition for treating the cerebrovascular diseases.
Preferably, in step S3, the solid-to-liquid ratio of the cichorium barometz and water is 1 g: 150-.
Preferably, in step S3, the boiling is performed at 100-110 ℃ for 4-6 hours.
The traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention has the following functions and effects:
acanthopanax senticosus: warm in nature, pungent and astringent in flavor, promoting blood circulation, removing toxic substance, and dispelling pathogenic wind and dampness, and can be used for treating headache, general pain, rheumatic numbness and wandering pain.
Acanthopanax gracilistylus: warm in nature, pungent and slightly bitter in flavor, dispel wind and dampness, dissipate blood stasis and dredge collaterals, detoxify and detumescence. Can be used for treating rheumatalgia, lumbar muscle strain, numbness of limbs, traumatic injury, blood stasis and swelling, fracture, carbuncle, swelling, and snake bite.
Rock acanthopanax bark: warm in nature, slightly bitter and astringent in taste, dispelling wind and removing dampness, dispelling cold and relieving pain, and relieving cough and asthma. Wind-damp arthralgia, epigastric pain, cough and asthma.
Rhizoma anemones Flaccidae: mild in nature, bland in flavor, clearing lung-heat, relieving cough, resolving phlegm. It is indicated for qi pain of heart and stomach, hematemesis, and is most suitable for pulmonary tuberculosis.
Camphor wood: warm in nature and slightly pungent in taste. Warm middle energizer and dispel cold, promote digestion and resolve stagnation. It is used to treat gastroenteritis, stomach cold, abdominal pain, dyspepsia, pertussis, and dysentery.
Mint: cool in nature and pungent in flavor. Disperse wind-heat, clear heat and improve eyesight, relieve sore throat and promote eruption, sooth liver and move qi. Wind-heat common cold, headache, sore throat, food stagnation and flatulence, aphtha, toothache, scabies, urticaria, initial epidemic febrile disease, rubella pruritus, stagnation of qi due to depression of the liver, chest distress and hypochondriac pain.
Acanthopanax bark: cool in nature, pungent and bitter in flavor. Dispel wind and dampness, activate blood and alleviate pain. It can be used for treating rheumatic arthralgia, lumbago due to overstrain, traumatic injury, fracture, and menoxenia.
Honey: mild in nature and sweet in taste. To regulate and nourish the spleen and stomach. Pain due to deficiency of the major epigastrium and abdomen; cough due to dryness of the lung; constipation due to intestinal dryness; conjunctival congestion; aphtha; unhealing ulcer; rubella with pruritus; scald by hot water or fire; rhagadia manus et pedis.
Pumpkin seed powder: mild in nature and sweet in taste. Has anthelmintic effect. Can be used for treating taeniasis and schistosomiasis.
Velvet: cool in nature and sweet in taste. Clear heat and resolve phlegm, cool blood and remove toxicity. Can be used for treating fever, polydipsia, cough, phlegm, asthma, hematochezia, hemorrhoid hemorrhage, bloody stranguria, metrorrhagia, superficial infection, pyocutaneous disease, galactostasis, undefined lump, and edema.
The application method of the traditional Chinese medicine composition for treating cerebrovascular diseases, provided by the invention, comprises the following steps: one spoon of honey (10g) is needed to take the traditional Chinese medicine composition for treating cerebrovascular diseases.
The traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention has contraindications: chinese medicinal composition for treating cerebrovascular diseases such as ovum gallus Domesticus, lean meat, and cake is administered after fasting.
The invention has the beneficial effects that:
(1) the traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention adopts natural traditional Chinese medicines as raw material components, is green and safe, does not contain hormone, has no side effect, is low in price, can be taken for a long time, is convenient to take, can replace the daily drinking behavior of patients, can drink water as medicine, is not limited in times every day, and is more effective when being taken frequently.
(2) The traditional Chinese medicine composition for treating cerebrovascular diseases has obvious effects on treating diseases caused by cerebrovascular blockage such as cerebral infarction, cerebral thrombosis, cerebral hemorrhage and the like, and the cure rate can reach more than 98%; the traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention needs two to three months for the cure cycle of the initial patient; the cure period of patients with longer disease age needs about half a year to one year; patients with an age of more than ten years will take from one year to two years.
(3) The traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention inherits the traditional Chinese medicine concept of Chinese nationality, takes conditioning as a main part, fundamentally solves various blockage and blockage problems in the cerebral vessels, and dredges the blood vessels to normally operate so as to achieve the aim of curing the disease condition.
(4) The preparation method of the traditional Chinese medicine composition for treating cerebrovascular diseases, provided by the invention, has the advantages of simple operation, stable technology, easily available raw materials, excellent effect of the prepared traditional Chinese medicine composition and great commercial value.
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
The traditional Chinese medicine composition for treating the cerebrovascular disease comprises the following raw material components in parts by weight:
25 parts of acanthopanax rubrus, 25 parts of acanthopanax giraldii harms, 25 parts of acanthopanax senticosus, 12.5 parts of rhynchophylla, 7.5 parts of cinnamomum camphora, 7.5 parts of mint, 25 parts of acanthopanax giraldii harms, 12.5 parts of pumpkin seed powder and 7.5 parts of luffa down.
The preparation method of the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following steps:
s1, mixing the acanthopanax giraldii harms, the acanthopanax yantheri and the acanthopanax giraldii harms, wrapping and winding the mixture by using gauze to prepare a medicine bag A;
s2, wrapping the pumpkin seed powder with gauze to obtain a medicine bag B;
s3, mixing the medicine bag A, the medicine bag B, the rhynchophylla, the camphor, the mint and the towel gourd velvet, adding water into the mixture, and decocting to obtain the traditional Chinese medicine composition for treating the cerebrovascular diseases.
In step S3, the solid-to-liquid ratio of the cichorus baccata to water is 1 g: 200 ml.
In step S3, the decoction is carried out for 6 hours at 110 ℃.
Example 2
The traditional Chinese medicine composition for treating the cerebrovascular disease comprises the following raw material components in parts by weight:
20 parts of acanthopanax rubrus, 20 parts of acanthopanax giraldii harms, 20 parts of acanthopanax gracilistylus, 10 parts of rhynchophylla, 5 parts of cinnamomum camphora, 5 parts of mint, 20 parts of acanthopanax giraldii harms, 10 parts of pumpkin seed powder and 5 parts of luffa down.
The preparation method of the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following steps:
s1, mixing the acanthopanax giraldii harms, the acanthopanax yantheri and the acanthopanax giraldii harms, wrapping and winding the mixture by using gauze to prepare a medicine bag A;
s2, wrapping the pumpkin seed powder with gauze to obtain a medicine bag B;
s3, mixing the medicine bag A, the medicine bag B, the rhynchophylla, the camphor, the mint and the towel gourd velvet, adding water into the mixture, and decocting to obtain the traditional Chinese medicine composition for treating the cerebrovascular diseases.
In step S3, the solid-to-liquid ratio of the cichorus baccata to water is 1 g: 200 ml.
In step S3, the decoction is carried out for 6 hours at 110 ℃.
Example 3
The traditional Chinese medicine composition for treating the cerebrovascular disease comprises the following raw material components in parts by weight:
30 parts of acanthopanax rubrus, 30 parts of acanthopanax giraldii harms, 30 parts of acanthopanax gracilistylus, 15 parts of rhynchophylla, 10 parts of cinnamomum camphora, 10 parts of mint, 30 parts of acanthopanax giraldii harms, 15 parts of pumpkin seed powder and 10 parts of towel gourd velvet.
The preparation method of the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following steps:
s1, mixing the acanthopanax giraldii harms, the acanthopanax yantheri and the acanthopanax giraldii harms, wrapping and winding the mixture by using gauze to prepare a medicine bag A;
s2, wrapping the pumpkin seed powder with gauze to obtain a medicine bag B;
s3, mixing the medicine bag A, the medicine bag B, the rhynchophylla, the camphor, the mint and the towel gourd velvet, adding water into the mixture, and decocting to obtain the traditional Chinese medicine composition for treating the cerebrovascular diseases.
In step S3, the solid-to-liquid ratio of the cichorus baccata to water is 1 g: 200 ml.
In step S3, the decoction is carried out for 6 hours at 110 ℃.
Test examples
Test of the Effect of the Chinese medicinal compositions for treating cerebrovascular diseases prepared in examples 1 to 3 on treating cerebral thrombosis
And (4) judging the standard:
and (3) healing: the function of the affected limb is basically recovered, the muscle strength is more than IV degrees, the language is fluent, and the life is self-care;
the effect is shown: the function of the affected limb is obviously recovered, the muscle strength is more than III degrees, and the affected limb can walk by leaning on a crutch;
the method has the following advantages: clear consciousness, more than II degrees of muscle strength;
and (4) invalidation: below the muscle force I DEG or no change.
The test method comprises the following steps: 300 patients with initial cerebral thrombosis were randomly selected, and were equally divided into 3 groups, and the Chinese medicinal composition for treating cerebrovascular diseases prepared in examples 1 to 3 was administered daily for 3 months at 1000ml per day for unlimited times, and during the administration period, eggs, lean meat, and cakes, which were the Chinese medicinal composition for treating cerebrovascular diseases, were fasted, and the results are shown in Table 1.
TABLE 1
| Example 1 | Example 2 | Example 3 | |
| Recovery method | 99 | 98 | 99 |
| Show effect | 1 | 1 | 0 |
| Is effective | 0 | 1 | 1 |
| Invalidation | 0 | 0 | 0 |
As can be seen from Table 1, the cure rate of the traditional Chinese medicine composition for treating cerebrovascular diseases provided by the invention can reach more than 98%.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (7)
1. A traditional Chinese medicine composition for treating cerebrovascular diseases is characterized in that: the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 20-30 parts of acanthopanax rubrus, 20-30 parts of acanthopanax giraldii harms, 20-30 parts of acanthopanax rupestris, 10-15 parts of rhynchophylla, 5-10 parts of cinnamomum camphora, 5-10 parts of mint, 20-30 parts of acanthopanax arborescens, 10-15 parts of pumpkin seed powder and 5-10 parts of towel gourd fruit.
2. The Chinese medicinal composition for treating cerebrovascular diseases according to claim 1, which is characterized in that: the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 25 parts of acanthopanax rubrus, 25 parts of acanthopanax giraldii harms, 25 parts of acanthopanax senticosus, 12.5 parts of rhynchophylla, 7.5 parts of cinnamomum camphora, 7.5 parts of mint, 25 parts of acanthopanax giraldii harms, 12.5 parts of pumpkin seed powder and 7.5 parts of luffa down.
3. The Chinese medicinal composition for treating cerebrovascular diseases according to claim 1, which is characterized in that: the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 20 parts of acanthopanax rubrus, 20 parts of acanthopanax giraldii harms, 20 parts of acanthopanax gracilistylus, 10 parts of rhynchophylla, 5 parts of cinnamomum camphora, 5 parts of mint, 20 parts of acanthopanax giraldii harms, 10 parts of pumpkin seed powder and 5 parts of luffa down.
4. The Chinese medicinal composition for treating cerebrovascular diseases according to claim 1, which is characterized in that: the traditional Chinese medicine composition for treating cerebrovascular diseases comprises the following raw material components in parts by weight: 30 parts of acanthopanax rubrus, 30 parts of acanthopanax giraldii harms, 30 parts of acanthopanax gracilistylus, 15 parts of rhynchophylla, 10 parts of cinnamomum camphora, 10 parts of mint, 30 parts of acanthopanax giraldii harms, 15 parts of pumpkin seed powder and 10 parts of towel gourd velvet.
5. The method for preparing a Chinese medicinal composition for treating cerebrovascular disease as claimed in any one of claims 1 to 4, wherein: the preparation method comprises the following steps: s1, mixing the acanthopanax giraldii harms, the acanthopanax yantheri and the acanthopanax giraldii harms, wrapping and winding the mixture by using gauze to prepare a medicine bag A; s2, wrapping the pumpkin seed powder with gauze to obtain a medicine bag B; s3, mixing the medicine bag A, the medicine bag B, the rhynchophylla, the camphor, the mint and the towel gourd velvet, adding water into the mixture, and decocting to obtain the traditional Chinese medicine composition for treating the cerebrovascular diseases.
6. The preparation method of the Chinese medicinal composition for treating cerebrovascular diseases according to claim 5, which is characterized in that: in step S3, the solid-to-liquid ratio of the cichorus baccata to water is 1 g: 150-.
7. The preparation method of the Chinese medicinal composition for treating cerebrovascular diseases according to claim 5, which is characterized in that: in step S3, the boiling is carried out at the temperature of 100 ℃ and 110 ℃ for 4-6 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111003503.0A CN113559183A (en) | 2021-08-30 | 2021-08-30 | A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111003503.0A CN113559183A (en) | 2021-08-30 | 2021-08-30 | A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113559183A true CN113559183A (en) | 2021-10-29 |
Family
ID=78173072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111003503.0A Pending CN113559183A (en) | 2021-08-30 | 2021-08-30 | A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113559183A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380131A (en) * | 2007-09-04 | 2009-03-11 | 于光 | Beverage produced by fruit from araliaceae shrub |
| CN104940314A (en) * | 2015-05-27 | 2015-09-30 | 刘保安 | Traditional Chinese medicine composition for treating paralysis |
| CN107129906A (en) * | 2017-07-09 | 2017-09-05 | 柴华 | A kind of brewing method of Gorgon fruit wine |
| CN111419958A (en) * | 2020-04-23 | 2020-07-17 | 唐荣成 | Traditional Chinese medicine composition for treating cerebrovascular accident sequelae and preparation method thereof |
-
2021
- 2021-08-30 CN CN202111003503.0A patent/CN113559183A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380131A (en) * | 2007-09-04 | 2009-03-11 | 于光 | Beverage produced by fruit from araliaceae shrub |
| CN104940314A (en) * | 2015-05-27 | 2015-09-30 | 刘保安 | Traditional Chinese medicine composition for treating paralysis |
| CN107129906A (en) * | 2017-07-09 | 2017-09-05 | 柴华 | A kind of brewing method of Gorgon fruit wine |
| CN111419958A (en) * | 2020-04-23 | 2020-07-17 | 唐荣成 | Traditional Chinese medicine composition for treating cerebrovascular accident sequelae and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 杨书良等: "HPLC法测定心脑泰滴丸中紫丁香苷", 《现代药物与临床》 * |
| 贾殿和，徐琳: "《常见病民间调理治疗方》", 31 August 2011, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112691130A (en) | Application of herba Aristolochiae rotundus and its extract in preparing medicine for treating gastrointestinal diseases and its pharmaceutical formulation | |
| CN104436119A (en) | Traditional Chinese medicine mixture for treating gaseous distention | |
| CN113559183A (en) | A Chinese medicinal composition for treating cerebrovascular diseases, and its preparation method | |
| CN109700930B (en) | Compound traditional Chinese medicine for treating gastric ulcer and duodenal ulcer | |
| CN107854613A (en) | A kind of pill medicine and preparation method that can effectively treat epigastric pain | |
| CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
| CN104984204A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN102688451A (en) | Chinese medicinal composition for treating alcoholic fatty liver | |
| CN108434403A (en) | Treat the patch and preparation method thereof of the proliferation of mammary gland | |
| CN107854685A (en) | A kind of Chinese medicine composition with antitumor action and its production and use | |
| CN106139114A (en) | A kind of for treating cold novel liniment in palace and preparation method thereof | |
| CN105770844A (en) | Medicine for treating gastric and duodenal ulcers and preparation method thereof | |
| CN113876744A (en) | Sanfu plaster for treating chronic bronchitis and preparation method thereof | |
| CN115708852A (en) | Naoxinshu preparation and its preparing method | |
| CN105641647A (en) | Bulbus fritillariae cirrhosae heat-clearing lung-moistening oral liquid and production method thereof | |
| CN105617229A (en) | Medicine for treating peptic ulcer | |
| CN105641372A (en) | Cortex dictamni wind-dispelling detoxifying health beverage and producing method thereof | |
| CN114767796A (en) | Composition for erosive gastritis and preparation method thereof | |
| CN116270841A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN110664976A (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method and application thereof | |
| CN109420124A (en) | A kind of Chinese medicine for treating gastritis | |
| CN107496561A (en) | A kind of decoction medicine for treating infantile cough and preparation method thereof | |
| CN107998362A (en) | A kind of Chinese medicine composition for treating stomach trouble, preparation method and application | |
| CN108853254A (en) | A kind of Chinese medicine composition of promoting blood circulation and breaking stagnation and its preparation method and application | |
| CN106822780A (en) | It is a kind of to treat the damp and hot Chinese medicine composition for stopping up resistance card of chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211029 |